Importer of Controlled Substances Application: Cardinal Health, 21764 [2021-08537]

Download as PDF 21764 Federal Register / Vol. 86, No. 77 / Friday, April 23, 2021 / Notices that an industry in the United States is materially injured by reason of imports of seamless carbon and alloy steel standard, line, and pressure pipe from Czechia, provided for in subheadings 7304.19.10, 7304.19.50, 7304.31.60, 7304.39.00, 7304.51.50, 7304.59.60, and 7304.59.80 of the Harmonized Tariff Schedule of the United States, that have been found by the U.S. Department of Commerce (‘‘Commerce’’) to be sold in the United States at less than fair value (‘‘LTFV’’).2 Background The Commission instituted this investigation effective July 8, 2020, following receipt of petitions filed with the Commission and Commerce by Vallourec Star, LP, Houston, Texas. The Commission scheduled the final phase of the investigation following notification of a preliminary determination by Commerce that imports of seamless carbon and alloy steel standard, line, and pressure pipe from Czechia were being sold at LTFV within the meaning of section 733(b) of the Act (19 U.S.C. 1673b(b)). Notice of the scheduling of the final phase of the Commission’s investigation and of a public hearing to be held in connection therewith was given by posting copies of the notice in the Office of the Secretary, U.S. International Trade Commission, Washington, DC, and by publishing the notice in the Federal Register of December 31, 2021 (85 FR 86946). In light of the restrictions on access to the Commission building due to the COVID–19 pandemic, the Commission conducted its hearing through written testimony and video conference on March 4, 2021. All persons who requested the opportunity were permitted to participate. khammond on DSKJM1Z7X2PROD with NOTICES The Commission made this determination pursuant to § 735(b) of the Act (19 U.S.C. 1673d(b)). It completed and filed its determination in this investigation on April 19, 2021. The views of the Commission are contained in USITC Publication 5183 (April 2021), entitled Seamless Carbon and Alloy Steel Standard, Line, and Pressure Pipe from Czechia: Investigation No. 731– TA–1529 (Final). [FR Doc. 2021–08442 Filed 4–22–21; 8:45 am] BILLING CODE 7020–02–P FR 12909 (March 5, 2021). VerDate Sep<11>2014 18:15 Apr 22, 2021 Drug Enforcement Administration [Docket No. DEA–820] Jkt 253001 business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). William T. McDermott, Assistant Administrator. [FR Doc. 2021–08537 Filed 4–22–21; 8:45 am] Importer of Controlled Substances Application: Cardinal Health BILLING CODE P Drug Enforcement Administration, Department of Justice. ACTION: Notice of application. DEPARTMENT OF JUSTICE AGENCY: Cardinal Health has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. SUMMARY: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 24, 2021. Such persons may also file a written request for a hearing on the application on or before May 24, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this is notice that on February 15, 2021 Cardinal Health, 15 Ingram Boulevard, La Vergne, Tennessee 37086–3630, applied to be registered as an importer of the following basic class(es) of controlled substance(s): DATES: Drug code Controlled substance Nabilone ....................... By order of the Commission. Issued: April 19, 2021. Lisa Barton, Secretary to the Commission. 2 86 DEPARTMENT OF JUSTICE I 7379 Schedule I II The company plans to import finished dosage unit products containing Nabilone for distribution. No other activity for this drug code is authorized for this registration. Approval of permit applications will occur only when the registrant’s PO 00000 Frm 00082 Fmt 4703 Sfmt 4703 Drug Enforcement Administration [Docket No. DEA–821] Importer of Controlled Substances Application: Lipomed Drug Enforcement Administration, Justice. AGENCY: ACTION: Notice of application. Lipomed has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. SUMMARY: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 24, 2021. Such persons may also file a written request for a hearing on the application on or before May 24, 2021. DATES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All request for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. ADDRESSES: In accordance with 21 CFR 1301.34(a), this is notice that on February 26, 2021, 150 Cambridgepark Drive, Suite 705, Cambridge, Massachusetts 02140, applied to be registered as an importer of the following basic class(es) of controlled substance(s): SUPPLEMENTARY INFORMATION: E:\FR\FM\23APN1.SGM 23APN1

Agencies

[Federal Register Volume 86, Number 77 (Friday, April 23, 2021)]
[Notices]
[Page 21764]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-08537]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-820]


Importer of Controlled Substances Application: Cardinal Health

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Cardinal Health has applied to be registered as an importer of 
basic class(es) of controlled substance(s). Refer to Supplemental 
Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before May 24, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before May 24, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a 
hearing must be sent to: Drug Enforcement Administration, Attn: 
Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All 
requests for a hearing should also be sent to: (1) Drug Enforcement 
Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, 
Springfield, Virginia 22152; and (2) Drug Enforcement Administration, 
Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, 
Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.34(a), this 
is notice that on February 15, 2021 Cardinal Health, 15 Ingram 
Boulevard, La Vergne, Tennessee 37086-3630, applied to be registered as 
an importer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
                                           Drug
          Controlled substance             code          Schedule
------------------------------------------------------------------------
Nabilone...............................     7379  II
------------------------------------------------------------------------

    The company plans to import finished dosage unit products 
containing Nabilone for distribution. No other activity for this drug 
code is authorized for this registration.
    Approval of permit applications will occur only when the 
registrant's business activity is consistent with what is authorized 
under 21 U.S.C. 952(a)(2).

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-08537 Filed 4-22-21; 8:45 am]
BILLING CODE P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.